Grant: Master's Award: Canada Graduate Scholarships
McGill University
$17,500.00
Does Metacognitive Training (MCT) Improve Neurocognitive Performance in Psychosis?
EF 2022-23
Résumé
Since its creation in 2007, metacognitive training (MCT) has been a well-documented and scientifically validated psychosis intervention used to address and decrease cognitive biases, reduce symptom severity and ameliorate deficits in areas such as social cognition (Moritz et al. 2022). This is an open-access, free and module-based intervention that has demonstrated benefits in individual and group-based assessment, which demonstrates its versatility and accessibility in treatment. Given the robust effects of metacognitive training (MCT) on improving symptomatology in psychosis and having high acceptability in the literature, routinizing MCT into clinical care has been suggested (Eichner et al. 2016). Recent work has demonstrated that in addition to proximal outcomes directly targeted in the intervention (such as positive symptoms and cognitive biases), benefits in distal outcomes (such as a decrease in negative symptoms and an increase in self-esteem) have also been observed (Penney et al. 2022). Examining whether this intervention can indirectly improve other deficits that are typical of schizophrenia and related psychotic disorders would make a valuable contribution to the field and potentially inform clinicians of additional benefits to MCT. For this reason, the proposed research will conduct a systematic review and meta-analysis on the effect of MCT on neurocognition in psychosis. Furthermore, future work through the CIHR-funded iCog Canada project will examine neurocognitive effects of remotely administered MCT compared to remotely administered cognitive remediation (CR), which is an intervention that directly targets and has demonstrated benefits to neurocognitive performance in psychosis.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
486407
Name
Jeffrey Clayton M
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Does Metacognitive Training (MCT) Improve Neurocognitive Performance in Psychosis?
Programtype2
Studentship Programs
Orgnameinp2
McGill University
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Cognitive Remediation; Metacognitive Training; Neurocognition; Psychosis Intervention; Remote Assessment; Schizophrenia
Abstract
Since its creation in 2007, metacognitive training (MCT) has been a well-documented and scientifically validated psychosis intervention used to address and decrease cognitive biases, reduce symptom severity and ameliorate deficits in areas such as social cognition (Moritz et al. 2022). This is an open-access, free and module-based intervention that has demonstrated benefits in individual and group-based assessment, which demonstrates its versatility and accessibility in treatment. Given the robust effects of metacognitive training (MCT) on improving symptomatology in psychosis and having high acceptability in the literature, routinizing MCT into clinical care has been suggested (Eichner et al. 2016). Recent work has demonstrated that in addition to proximal outcomes directly targeted in the intervention (such as positive symptoms and cognitive biases), benefits in distal outcomes (such as a decrease in negative symptoms and an increase in self-esteem) have also been observed (Penney et al. 2022). Examining whether this intervention can indirectly improve other deficits that are typical of schizophrenia and related psychotic disorders would make a valuable contribution to the field and potentially inform clinicians of additional benefits to MCT. For this reason, the proposed research will conduct a systematic review and meta-analysis on the effect of MCT on neurocognition in psychosis. Furthermore, future work through the CIHR-funded iCog Canada project will examine neurocognitive effects of remotely administered MCT compared to remotely administered cognitive remediation (CR), which is an intervention that directly targets and has demonstrated benefits to neurocognitive performance in psychosis.
Competitiondate
202212
Approvedterm2
1 yr 0 mth
Pinamesdelim
Jeffrey, Clayton M
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~